Accessibility Menu
Mustang Bio logo

Mustang Bio

(NASDAQ) MBIO

Current Price$0.67
Market Cap$5.11M
Since IPO (2017)-100%
5 Year-100%
1 Year-36%
1 Month+7%

Mustang Bio Financials at a Glance

Market Cap

$5.11M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.72M

EPS (TTM)

-$0.48

P/E Ratio

-1.40

Dividend

$0.00

Beta (Volatility)

1.37 (Average)

Price

$0.67

Volume

8,274

Open

$0.67

Previous Close

$0.67

Daily Range

$0.64 - $0.67

52-Week Range

$0.53 - $7.00

Estimated Earnings Date

Aug 18, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mustang Bio

Industry

Biotechnology

Employees

4

CEO

Manuel Litchman, MD

Headquarters

Worcester, MA 01605, US

MBIO Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-45%

Return on Capital

-37%

Return on Assets

-16%

Earnings Yield

-71.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.11M

Shares Outstanding

7.58M

Volume

8.27K

Avg. Volume

131.04K

Financials (TTM)

Gross Profit

-$41.00K

Operating Income

-$2.43M

EBITDA

-$1.88M

Operating Cash Flow

-$5.26M

Capital Expenditure

$0.00

Free Cash Flow

-$5.26M

Cash & ST Invst.

$17.27M

Total Debt

$0.00

Mustang Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$5.11M

N/A

Market Cap/Employee

$851.20K

N/A

Employees

6

N/A

Net Income

-$955.00K

-524.2%

EBITDA

-$955.00K

-752.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$16.26M

+14.2%

Total Debt

$0.00

N/A

Accounts Receivable

$217.00K

-53.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-16.42%

N/A

Return on Invested Capital

-37.01%

N/A

Free Cash Flow

-$1.01M

+27.4%

Operating Cash Flow

-$1.01M

+27.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RNAZTransCode Therapeutics, Inc.
$4.85-3.00%
EVGNEvogene Ltd.
$0.49-0.98%
IMRNImmuron Limited
$1.13-1.96%
DWTXDogwood Therapeutics, Inc.
$1.52-1.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$36.93+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$82.58-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.37+0.02%
ICCMIceCure Medical
$5.93+0.10%

Questions About MBIO

What is the current price of Mustang Bio?

Mustang Bio is trading at $0.67 per share.

What is the 52-week range for Mustang Bio?

Over the past 52 weeks, Mustang Bio has traded between $0.53 and $7.00.

How much debt does Mustang Bio have?

As of the most recent reporting period, Mustang Bio reported total debt of $0.00.

How much cash does Mustang Bio have on hand?

Mustang Bio reported $16.26M in cash and cash equivalents in its most recent financial results.

What is Mustang Bio’s dividend yield?

Mustang Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.